详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Lin, Tianxin[1,2,3,4,5,6,7,8] * ; Li, Kaiwen[1,2,3,4,5,6,7,8] ; Fan, Jinhai[1,2,3,4,5,6,7,8] ; Wang, Shaogang[1,2,3,4,5,6,7,8]

; Yu, Dexin[1,2,3,4,5,6,7,8] ; Xu, Tao[1,2,3,4,5,6,7,8]

; Lyu, Jiaju[1,2,3,4,5,6,7,8] ; Qin, Tao[1,2,3,4,5,6,7,8] ; Liu, Zheng[1,2,3,4,5,6,7,8]

; Wu, Kaijie[1,2,3,4,5,6,7,8] ; Wang, Jinyou[1,2,3,4,5,6,7,8] ; Wang, Qi[1,2,3,4,5,6,7,8] ; Min, Jie[1,2,3,4,5,6,7,8]

; Hu, Zhiquan[1,2,3,4,5,6,7,8]

; Li, Fan[1,2,3,4,5,6,7,8]

; Zhang, Zhiqiang[1,2,3,4,5,6,7,8] ; Yu, Luping[1,2,3,4,5,6,7,8] ; Ding, Sentai[1,2,3,4,5,6,7,8] ; Huang, Jian[1,2,3,4,5,6,7,8] ;

单位： [1]Sun Yat Sen Univ, Dept Urol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [2]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian, Peoples R China [3]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Wuhan,Peoples R China [4]Anhui Med Univ, Hosp 2, Dept Urol, Hefei, Peoples R China [5]Peking Univ, Peoples Hosp, Dept Urol, Beijing, Peoples R China [6]Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan, Peoples R China [7]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou, Peoples R China [8]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Urol,Wuhan,Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Sun Yat Sen Univ, Dept Urol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [2]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian, Peoples R China [3]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Wuhan,Peoples R China [4]Anhui Med Univ, Hosp 2, Dept Urol, Hefei, Peoples R China [5]Peking Univ, Peoples Hosp, Dept Urol, Beijing, Peoples R China [6]Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan, Peoples R China [7]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou, Peoples R China [8]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Urol,Wuhan,Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Final analysis results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy in patients with cT2-T4aN0M0 MIBC

文献详情